🧵 Drug vs Disease — When Side Effects Mimic the Diagnosis👇
Is it the disease—or the drug? Many “flares” are actually medication effects. Here’s a clinic-ready guide to the most common drug–disease confusions, what to check, and how to pivot fast. Save and share. #MedTwitter #RheumTwitter #FOAMed #IMTwitter #PrimaryCare #PatientSafety @IhabFathiSulima @DrAkhilX @Janetbirdope
Post 1
Big idea
Before escalating therapy, ask: could the medication be causing or unmasking the symptom? Use this checklist: timing vs start/dose change, dose–response, dechallenge/rechallenge, and alternative explanations.
Post 2
NSAIDs vs kidney/pressure
•Looks like: edema, rising creatinine, “worsening gout/OA pain”
•Could be: NSAID nephrotoxicity or hypertension
•Check: creatinine/eGFR, BP, volume status; step down NSAID, switch to topical or COX-2 cautiously; renal-safe analgesia plan.
Post 3
Steroids vs infection
•Looks like: “rheum flare” with fatigue, tachycardia
•Could be: masked infection on steroids
•Check: vitals, WBC, CRP trend (can be blunted), focal symptoms; lower steroid if safe; rule out sepsis before increasing.
Post 5
Methotrexate vs disease fatigue
•Looks like: persistent fatigue, nausea, mouth soreness “despite control”
•Could be: MTX intolerance or cytopenia
•Check: CBC, LFTs, MCV; confirm weekly dosing; optimize folate/folinic acid; consider SC MTX or switch.
Post 6
Hydroxychloroquine vs vision complaints
•Looks like: “ocular flare” or headache
•Could be: HCQ toxicity (rare early but risk accumulates)
•Check: dose by actual body weight, cumulative dose, baseline/periodic ocular exams; if visual symptoms, urgent ophthalmology.
Post 7
Allopurinol vs “gout rash”
•Looks like: flare plus rash after ULT start
•Could be: hypersensitivity (watch for fever, eosinophilia, renal involvement)
•Check: timeline to start, skin exam, labs; stop drug and escalate care if systemic features; consider HLA-B*58:01 in high-risk groups where recommended.
Post 8
Colchicine vs neuropathy/diarrhea
•Looks like: “worsening enthesitis pain” with leg weakness
•Could be: colchicine toxicity (especially with CKD or interacting CYP3A4/P-gp drugs)
•Check: CK, neuro exam, meds for interactions; dose-adjust or stop; educate on early GI signs.
Post 9
Biologics/JAKi vs infection or paradoxical inflammation
•Looks like: “psoriasis flare” on anti-TNF, “cough/fever” on therapy
•Could be: paradoxical skin disease; opportunistic infection
•Check: TB/hepatitis screening status, CRP, CXR if respiratory; dermatology/rheum plan—switch class if paradoxical.
Post 10
PPIs vs hypomagnesemia/myalgia
•Looks like: diffuse aches “not improving with DMARDs”
•Could be: electrolyte disturbance from chronic PPI
•Check: Mg2+, Ca2+, vitamin B12 if long-term; step-down strategy or alternate GI protection if appropriate.
Post 11
Statins vs myopathy vs myositis
•Looks like: “polymyalgia” or proximal weakness
•Could be: statin myopathy or rare statin-associated autoimmune myopathy
•Check: CK, pattern (pain vs weakness), temporal relation; stop statin trial, consider alternate lipid therapy; if severe weakness/high CK, evaluate for SAAM.
Post 12
ACEi/ARBs vs cough/angioedema mimicking vasculitis
•Looks like: chronic cough/airway symptoms
•Could be: ACEi cough or rare angioedema
•Check: drug list and timing; switch class; reassess before extensive vasculitis workup.
Post 13
Diagnostic pause card
Before increasing immunosuppression, run the 5 checks:
1.Timeline to med change
2.Lab signal fits drug toxicity?
3.Dechallenge feasible?
4.Interactions/organ function reviewed?
5.A single test to clarify? (e.g., CK, UA, CXR)
Post 14
What to document
•Working differential (disease activity vs adverse effect)
•Safety labs and thresholds
•Proposed dechallenge/rechallenge plan
•Patient counseling and red-flag symptoms
•Exact follow-up date/window
Post 15
Shareable takeaways
•Not every “flare” is the disease.
•Start low, go slow, review often.
•One quick lab or med switch can prevent months of overtreatment.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
🧵 Steroid Stewardship & Safe Tapering: A Practical Playbook👇
For clinicians across primary care, rheumatology, IM, EM, and dermatology
Steroids help fast—but harm fast without a plan. Here’s a concise, clinic-ready playbook: when to start, how to taper, who needs bone/GI/infection protection, and when to escalate. Save this thread, share with teams, and use it tomorrow. #RheumTwitter #MedTwitter #FOAMed #PatientSafety #PrimaryCare #IMTwitter
@IhabFathiSulima @DrAkhilX @ACRheum @IRAeNewsLetter @DurgaPrasannaM1 @CelestinoGutirr @NeuroSjogrens @nirmalregency @Janetbirdope @Lupusreference #MedTwitter #Rheumatology #RheumTwitter #PrimaryCare #GP #IMTwitter
Post 1
Steroids help fast—but harm fast if misused. Goals: shortest duration, lowest dose, clear taper, bone protection, and an exit plan. Save for clinic.
#MedTwitter #RheumTwitter #FOAMed #GP #PrimaryCare
Post 2
Before starting prednisone:
•Confirm inflammatory indication (not purely mechanical pain)
•Baseline: BP, weight, glucose, ±lipids; vaccine status
•Agree on dose, duration, taper, monitoring, rescue plan
#PatientSafety #ClinicalTips #IMTwitter
Clinical Rheumatology Thread for Busy GPs:
Post 1
Early inflammatory arthritis(IA): the 3–3–3 rule
•Onset ≤3 months
•Morning stiffness ≥30–60 minutes
•≥3 swollen joints (MCP/MTP common)
If present, manage as IA: urgent rheum referral; NSAIDs if no contraindications.
@IhabFathiSulima @DrAkhilX @DurgaPrasannaM1 @Janetbirdope @ACRheum @RheumNow @Amansharmapgi @12VRavindran #MedTwitter #Rheumatology
Post 2
Red flags over patterns
Screen for: systemic (fever, weight loss, night sweats), vascular (new headache >50y, jaw/limb claudication), neuro/renal (hematuria, neuropathy).
Any present → same-week labs (CBC, ESR/CRP, creatinine, urinalysis) and escalate.
Post 3
Morning stiffness as a clue
60–90 min: inflammatory (RA, PMR, axial SpA)
•<30 min: mechanical (OA)
Pair with distribution: small joints=RA; spine/SI=axSpA; DIPs=PsA/OA.
đź§µ 2025 AHA Hypertension Guidelines: Changes & New Updates 1/ The 2025 AHA/ACC hypertension guideline replaces the 2017 version with key, evidence-driven changes. Here are the must-know updates for your clinical practice.
@IhabFathiSulima @DrAkhilX @TrackYourHeart @sumersethi @Mahmoud33986639 @latchumanadhas #MedTwitter
2/ PREVENT Risk Equation Now Central
All therapy decisions now use the PREVENT risk score (not pooled cohort equations). The 10-year CVD risk threshold to start medication is now ≥7.5%—so more patients, especially with moderate risk, will get earlier treatment.
3/ Initiation of Therapy at Lower Thresholds
Stage 1 hypertension (130–139/80–89 mm Hg):
•If CVD, CKD, diabetes, or PREVENT risk ≥7.5%, start antihypertensive immediately.
•If PREVENT risk <7.5%: start with lifestyle changes for 3–6 months. If BP stays ≥130/80, add medication.
This expands eligibility —more aggressive than 2017.
🧵 Hematological Manifestations in Autoimmune Diseases—2025 Clinical Update 1/ Blood disorders are common in autoimmune diseases and may be the first clue. Timely recognition can be lifesaving. Here’s a crisp clinical thread every practitioner should bookmark.
@IhabFathiSulima @DrAkhilX @CelestinoGutirr @HematologyAdv @EHA_Hematology #MedTwitter #Rheumatology
2/ 🦋 Lupus (SLE):
•Anemia (iron-deficiency, hemolytic, chronic disease, drug-induced)
•Lymphopenia
•Thrombocytopenia (may be severe)
All correlate with disease activity and need close monitoring.
3/ 🤲 Rheumatoid Arthritis (RA):
•Anemia of chronic disease
•Felty’s syndrome: RA + big spleen + neutropenia
•Drug-induced cytopenias (MTX, biologics)
•Blood markers (Hb, NLR) can predict flare/remission.
🧵 ANA (Antinuclear Antibody): What Every GP Needs To Know—2025 Guide
1/ What is ANA—and Why Test It?
ANA is a blood test that helps detect autoantibodies against cell nuclei, seen in autoimmune diseases like lupus, Sjögren’s, and more. It’s NOT a screening test for general complaints. Use it when history or exam genuinely points to autoimmune disorders
@IhabFathiSulima @DrAkhilX @CelestinoGutirr @Janetbirdope @SarahSchaferMD @NeuroSjogrens #MedTwitter #RheumatX
2/ Who Should Be Tested?
Test ANA only when you see signs such as:
•Unexplained, non-infectious joint pain/swelling
•Persistent rash, especially photosensitive
•Raynaud’s phenomenon
•Sicca symptoms (dry eyes/mouth)
•Multi-system symptoms (e.g., nephritis, serositis)
3/ How To Interpret ANA Results
•Negative ANA: Very low likelihood of connective tissue disease, but rarely rules out all autoimmune illness.
•Positive ANA: Means autoantibodies were detected, but CAUTION! Many healthy people, especially elderly and women, can test positive.
đź§µ Red Flag Symptoms NOT to Miss in Rheumatic Diseases
1/ Systemic (Whole-Body) Red Flags
•Fever, unexplained weight loss, night sweats, loss of appetite, persistent fatigue
•Malaise or feeling generally unwell, lymph node swelling, new pallor
These often signal serious underlying inflammation, infection, or even malignancy.
@IhabFathiSulima @DrAkhilX @CelestinoGutirr @SarahSchaferMD @NeuroSjogrens #MedTwitter #Rheumatology
2/ Pain and Swelling Not Acting Like “Usual Arthritis”
•Acute, severe, or rapidly increasing joint pain (especially a single hot, swollen joint)
•Bone pain, deep/throbbing—not just joint tenderness
•Recurrent or migratory joint pain, especially with redness or heat.
3/ Night Pains & Persistent Symptoms
•Pain waking you up at night and not eased with usual pain relief
•Stiffness that lasts more than an hour in the morning or after inactivity.